Valued at USD 23.47 billion in 2024, the global joint replacement devices market is projected to reach USD 24.52 billion in 2025 and USD 37.01 billion by 2034, growing at a CAGR of 4.7% during the forecast period 2025–2034. Competition spans global medical device manufacturers and emerging orthopedic technology firms, including Globus Medical, Inc.; Medacta International; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; and Orthofix Medical Inc.

Healthcare Spending in Emerging Nations

The joint replacement devices market is driven by growing healthcare spending in emerging nations. Governments and private sectors are investing heavily in healthcare infrastructure, making surgeries available to a larger population, while higher budgets improve insurance coverage and reimbursement policies. The share of Government Health Expenditure in India's GDP increased from 1.13% in 2014–15 to 1.84% in 2021–22. This spending is also fueling medical tourism in countries such as India and Brazil. Many individuals previously avoided replacement surgeries because of high costs, but with increased government support and private health insurance plans, more patients are undergoing knee, hip and shoulder replacement surgeries.

Hospitals & Surgical Centers Dominate End Use

By end user, the market is segregated into hospitals & surgical centers, ambulatory care centers & trauma units, and others. Hospitals & surgical centers accounted for a major share in 2024 owing to the high volume of procedures performed in these facilities. Patients favor them for advanced medical technology, highly skilled orthopedic surgeons and comprehensive post-operative care. Surgical suites are equipped with robotic-assisted systems and 3D imaging that improve precision, and multidisciplinary teams, including anesthesiologists, physical therapists and pain management specialists, support better outcomes and faster recovery. Government and private healthcare investments have further strengthened hospital infrastructure, increasing accessibility for patients worldwide.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/joint-replacement-devices-market

Implant Longevity and Revision Surgeries

By surgery type, the report covers total, partial and revision replacement. Improved implant materials, including highly cross-linked polyethylene and ceramic components, have extended implant longevity, reducing the need for revision surgeries. These technological advances, combined with increasing healthcare investment and favorable reimbursement policies, have strengthened the leading product segment. Johnson & Johnson's WATSON EXTRACTION SYSTEM simplifies the removal of femoral implants during revision surgeries, reducing surgery time and improving predictability.

Shoulder Replacement Innovation

Product segmentation also includes shoulder replacement and wrist replacement. In October 2025, DePuy Synthes, part of Johnson & Johnson, launched the INHANCE INTACT total shoulder replacement system in the US. The system incorporates a tissue-sparing approach that preserves the subscapularis muscle, enabling enhanced recovery protocols and allowing patients to begin mobility as early as the first day after surgery.

Regional Outlook

North America dominated in 2024, supported by favorable reimbursement policies and comprehensive health insurance coverage that reduce the financial burden of surgery, and many hospitals and specialized orthopedic centers offer advanced treatment options. Asia Pacific is estimated to grow at a rapid pace, owing to its expanding healthcare sector, growing elderly population and increasing incidence of joint disorders. China, India and Japan are witnessing a surge in demand for orthopedic procedures due to lifestyle changes and urbanization, and international manufacturers are expanding their presence with innovative implants and robotic-assisted surgical systems.

Competitive Landscape and Recent Developments

The competitive landscape is characterized by global medical device manufacturers, emerging orthopedic technology firms and strategic collaborations focused on innovation and market expansion. Companies are investing in advanced biomaterials, 3D printing and robotic-assisted surgery to enhance durability and precision. Regulatory approvals, reimbursement policies and clinical trial data significantly influence market positioning, and growing demand for personalized implants, minimally invasive procedures and AI-driven surgical planning tools intensifies competition. Strategic mergers and acquisitions and partnerships with healthcare providers drive market penetration. In August 2024, Exactech launched ExactechGPS computer-assisted technology for total knee procedures, and in January 2023, Aster Medcity launched joint replacement devices, including robots for knee surgeries. High cost and lack of awareness in underdeveloped nations remain a restraint.

More Trending Latest Reports By Polaris Market Research:

top-10-uv-nail-gel-brands-in-north-america-2025

induced-pluripotent-stem-cell-ipsc-market

melamine-market

non-small-cell-lung-cancer-market

benzene-market

global-specialty-generic-drugs-market

automated-medical-washer-disinfector-market

green-ammonia-market

analytical-instrumentation-market